The FDA has approved a first-of-its-kind treatment for dry age-related macular degeneration (AMD), a leading cause of blindness in adults over 55.

SolidddVision smart glasses aim to restore vision for people living with macular degeneration, a condition that affects ...

A specialty pharmacy company agreed to a $1.67 million settlement that it gave inventory management systems to retina ...

Phase 1b clinical data underpins sozinibercept’s potential as a novel, first-in-class VEGF-C/D ‘trap’ to improve visual and anatomic outcomes in ...

Astellas Pharma Inc. (ALPMY, ALPMY) announced that the U.S. Food and Drug Administration accepted the revised supplemental New Drug ...

Fresenius, through its operating company Fresenius Kabi, is broadening its growing biopharma portfolio through a new licensing agreement with South Korea’s SamChunDang Pharm. Under the agreement, ...

These are the best vitamins and supplements for eye health, which are great for supporting your vision and helping you take ...

Toll-like receptors (TLRs) are vital components of the immune system, acting as sentinels that detect and respond to ...

Lenvatinib is under clinical development by AiViva BioPharma and currently in Phase II for Diabetic Macular Edema.

According to the American Kennel Club (AKC), vision loss in older dogs can stem from conditions like cataracts, glaucoma, ...

CES 2025 is just around the corner, and our favorite companies are showing off their latest and greatest tech early. One of those companies is Solidd.